Alpha radiation treatment for vulvar squamous cell carcinoma
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new device that delivers alpha radiation directly to vulvar cancer tumors. It is for women with newly diagnosed or returning squamous cell carcinoma of the vulva, and aims to treat the tumor while limiting damage to nearby healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have squamous cell carcinoma of the vulva, either newly diagnosed or returning within 12 months.
- The tumor is 7 cm or smaller at its longest point.
- You are at least 18 years old and have a life expectancy of 6 months or more.
- You have not had chemotherapy or immunotherapy in the past 4 weeks.
- You are able to undergo the procedure as decided by your medical team.
- You are willing to use birth control for 3 months after treatment if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special radiation device (DaRT) placed directly into skin cancer tumors. It is designed for patients with weakened immune systems (immunocompromised) who have a single skin cancer lesion on the skin (not spread elsewhere).
This trial tests a radiation-emitting device placed near the tumor to treat certain malignant skin cancers that can be fully covered. It may help shrink or control the cancer at the skin site where the device is applied.
This trial tests a new type of radiation therapy (DaRT) that uses tiny, implantable seeds to deliver targeted alpha radiation to breast tumors. It is designed for older patients (65+) or those who are too frail for surgery, offering a less invasive option for controlling the cancer.
This Phase 2 trial compares two treatment approaches for some women with vulvar squamous cell cancer: chemoradiation first, or chemotherapy first followed by surgery. The goal is to see which strategy works better or is safer for tumors that are hard to remove without major pelvic surgery.
This trial tests a treatment that places tiny radiation “seeds” inside/near the chest tumor to treat recurrent lung cancer. It may help people whose cancer has come back and can be safely reached by the radiation device.
This trial tests a new treatment using tiny alpha radiation implants directly into the prostate for prostate cancer that has come back after initial treatment. It may be an option for people with a local recurrence who are eligible for focal salvage therapy.
Hear when a new Carcinoma of the Vulva trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.